Loading organizations...
Loading organizations...
Biotherapeutics company using single-cell technologies for drug discovery.
HiFiBiO has raised $179.5M across 3 funding rounds.
HiFiBiO has raised $179.5M in total across 3 funding rounds.
HiFiBiO has raised $179.5M in total across 3 funding rounds.
HiFiBiO's investors include Ryan Jeong, B Capital Group, Grand Mount, Hong Kong Science and Technology Parks Corporation, IDG Capital, Maison Capital, Sequoia Capital, Sherpa, Trinity Innovation Fund, Delian Capital, Hanne Capital, Hongshan Capital Group (Sequoia Capital China).
HiFiBiO has raised $179.5M across 3 funding rounds. Most recently, it raised $75.0M Series D in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 14, 2021 | $75.0M Series D | Ryan Jeong | B Capital Group, Grand Mount, Hong Kong Science and Technology Parks Corporation, IDG Capital, Maison Capital, Sequoia Capital, Sherpa, Trinity Innovation Fund |
| Aug 28, 2019 | $67.0M Series C | IDG Capital | Delian Capital, Hanne Capital, Hongshan Capital Group (Sequoia Capital China), Kite, LYFE Capital, VI Ventures |
| May 16, 2018 | $37.5M Series B | Lynn Yang, James Zhao | Nest.Bio Ventures, Proxima Ventures, VI Ventures |